Teva Can Market Generic Provigil Three Years Before Patent Expiration
This article was originally published in The Pink Sheet Daily
Executive Summary
Under a settlement with Cephalon, Teva’s modafinil can enter the market in 2011 or 2012, depending on a potential pediatric extension.